The role of epoxide hydrolases in health and disease

Archives of Toxicology

Volumn 88, Issue 11, 2014, Pages 2013-2032

  El Sherbeni, Ahmed A ^a   El Kadi, Ayman O S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Epoxides; Epoxyeicosatrienoic acids; Epoxyoctadecenoic acids; Polymorphism; Reactive metabolites; Xenobiotics

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL EPOXIDE HYDROLASE; ENZYME INHIBITOR; EPOXIDE; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE INHIBITOR; FENOFIBRATE; HEPOXILIN EPOXIDE HYDROLASE; LEUKOTRIENE A4 EPOXIDE HYDROLASE; LINOLEIC ACID; MICROSOME ENZYME; ROSIGLITAZONE; STYRENE; STYRENE OXIDE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

CARDIOVASCULAR SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; DETOXIFICATION; DRUG MECHANISM; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME POLYMORPHISM; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; INFLAMMATION; NONHUMAN; PAIN; PROTEIN EXPRESSION; REVIEW; ANIMAL; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MICROSOME;

ANIMALS; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; HUMANS; MICROSOMES; POLYMORPHISM, GENETIC; XENOBIOTICS;

EID: 84919844064     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1371-y     Document Type: Review

References (185)

1. Abdel-Rahman SZ, Ammenheuser MM, Omiecinski CJ, Wickliffe JK, Rosenblatt JI, Ward JB Jr (2005) Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5′-flanking region of the microsomal epoxide hydrolase gene (EPHX1). Toxicol Sci 85(1):624–631. doi:10.1093/toxsci/kfi115
2. Aboutabl ME, Zordoky BN, Hammock BD, El-Kadi AO (2011) Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene. J Cardiovasc Pharmacol 57(3):273–281. doi:10.1097/FJC.0b013e3182055baf00005344-201103000-00001
3. Arand M, Cronin A, Oesch F, Mowbray SL, Jones TA (2003) The telltale structures of epoxide hydrolases. Drug Metab Rev 35(4):365–383. doi:10.1081/DMR-120026498
4. Argiriadi MA, Morisseau C, Hammock BD, Christianson DW (1999) Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. Proc Natl Acad Sci USA 96(19):10637–10642
5. Armstrong RN (1987) Enzyme-catalyzed detoxication reactions: mechanisms and stereochemistry. CRC Crit Rev Biochem 22(1):39–88
6. Armstrong RN (1999) Kinetic and chemical mechanism of epoxide hydrolase. Drug Metab Rev 31(1):71–86. doi:10.1081/DMR-100101908
7. Bauer AK, Faiola B, Abernethy DJ et al (2003) Male mice deficient in microsomal epoxide hydrolase are not susceptible to benzene-induced toxicity. Toxicol Sci 72(2):201–209. doi:10.1093/toxsci/kfg024
8. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A (1998) Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 58(23):5291–5293
9. Bhaskar LV, Thangaraj K, Patel M et al (2013) EPHX1 Gene Polymorphisms in Alcohol Dependence and their Distribution among the Indian Populations. Am J Drug Alcohol Abuse 39(1):16–22. doi:10.3109/00952990.2011.643991
10. Borhan B, Jones AD, Pinot F, Grant DF, Kurth MJ, Hammock BD (1995) Mechanism of soluble epoxide hydrolase. Formation of an alpha-hydroxy ester-enzyme intermediate through Asp-333. J Biol Chem 270(45):26923–26930
11. Burdon KP, Lehtinen AB, Langefeld CD et al (2008) Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study. Diab Vasc Dis Res 5(2):128–134. doi:10.3132/dvdr.2008.021
12. Campbell WB (2000) New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends Pharmacol Sci 21(4):125–127. doi:10.1016/S0165-6147(00)01472-3
13. Cannady EA, Dyer CA, Christian PJ, Sipes IG, Hoyer PB (2002) Expression and activity of microsomal epoxide hydrolase in follicles isolated from mouse ovaries. Toxicol Sci 68(1):24–31
14. Capdevila JH, Falck JR, Harris RC (2000) Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 41(2):163–181
15. Carlson GP (1998) Metabolism of styrene oxide to styrene glycol by mouse liver and lung. J Toxicol Environ Health A 53(1):19–27. doi:10.1080/009841098159448
16. Chaudhary KR, Abukhashim M, Hwang SH, Hammock BD, Seubert JM (2010) Inhibition of soluble epoxide hydrolase by trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury. J Cardiovasc Pharmacol 55(1):67–73. doi:10.1097/FJC.0b013e3181c37d69
17. Chen X, Wang S, Wu N, Yang CS (2004) Leukotriene A4 hydrolase as a target for cancer prevention and therapy. Curr Cancer Drug Targets 4(3):267–283
18. Cho MK, Kim SG (1998) Differential induction of rat hepatic microsomal epoxide hydrolase and rGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation. Chem Biol Interact 116(3):229–245. doi:10.1016/S0009-2797(98)00093-3
19. Cho WS, Han BS, Nam KT et al (2008) Carcinogenicity study of 3-monochloropropane-1,2-diol in Sprague-Dawley rats. Food Chem Toxicol 46(9):3172–3177. doi:10.1016/j.fct.2008.07
20. Conolly RB, Szabo S, Jaeger RJ (1979) Vinylidene fluoride: acute hepatotoxicity in rats pretreated with PCB or phenobarbital. Proc Soc Exp Biol Med 162(1):163–169
21. Costa C, Costa S, Silva S et al (2012) DNA damage and susceptibility assessment in industrial workers exposed to styrene. J Toxicol Environ Health A 75(13–15):735–746. doi:10.1080/15287394.2012.688488
22. Cronin A, Decker M, Arand M (2011) Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase. J Lipid Res 52(4):712–719. doi:10.1194/jlr.M009639
23. Davis BB, Liu JY, Tancredi DJ et al (2011) The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment. Biochem Biophys Res Commun 410(3):494–500. doi:10.1016/j.bbrc.2011.06.008
24. de Assis S, Ambrosone CB, Wustrack S, Krishnan S, Freudenheim JL, Shields PG (2002) Microsomal epoxide hydrolase variants are not associated with risk of breast cancer. Cancer Epidemiol Biomarkers Prev 11(12):1697–1698
25. De Berardinis V, Moulis C, Maurice M et al (2000) Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 58(3):542–551
26. de Jong DJ, van der Logt EM, van Schaik A, Roelofs HM, Peters WH, Naber TH (2003) Genetic polymorphisms in biotransformation enzymes in Crohn’s disease: association with microsomal epoxide hydrolase. Gut 52(4):547–551
27. de Medina P, Paillasse MR, Segala G, Poirot M, Silvente-Poirot S (2010) Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands. Proc Natl Acad Sci USA 107(30):13520–13525. doi:10.1073/pnas.1002922107
28. Decker M, Arand M, Cronin A (2009) Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch Toxicol 83(4):297–318. doi:10.1007/s00204-009-0416-0
29. Decker M, Adamska M, Cronin A et al (2012) EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides. J Lipid Res 53(10):2038–2045. doi:10.1194/jlr.M024448
30. Disse B, Siekmann L, Breuer H (1980) Biosynthesis of 16 alpha, 17 alpha-epoxy-4-androsten-3-one in rat liver microsomes. Acta Endocrinol (Copenh) 95(1):58–66
31. Draper AJ, Hammock BD (1999) Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals. Toxicol Sci 52(1):26–32
32. Draper AJ, Hammock BD (2000) Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase. Arch Biochem Biophys 376(1):199–205. doi:10.1006/abbi.2000.1705
33. Duale N, Bjellaas T, Alexander J et al (2009) Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes. Toxicol Sci 108(1):90–99. doi:10.1093/toxsci/kfn269
34. Dura P, Bregitha CV, Te Morsche RH et al (2012) EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians. Oncol Rep 27(6):1710–1716. doi:10.3892/or.2012.1734
35. Eldrup AB, Soleymanzadeh F, Taylor SJ et al (2009) Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J Med Chem 52(19):5880–5895. doi:10.1021/jm9005302
36. El-Sherbeni AA, El-Kadi AO (2014) Characterization of Arachidonic Acid Metabolism by Rat Cytochrome P450 Enzymes: the Involvement of CYP1As. Drug Metab Dispos 42(9):1498–1507. doi:10.1124/dmd.114.057836
37. Enayetallah AE, French RA, Barber M, Grant DF (2006) Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues. J Histochem Cytochem 54(3):329–335. doi:10.1369/jhc.5A6808.2005
38. Eugster HP, Sengstag C, Hinnen A, Meyer UA, Wurgler FE (1991) Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction. Biochem Pharmacol 42(7):1367–1372
39. Feil VJ, Hedde RD, Zaylskie RG, Zachrison CH (1970) Dieldrin- 14 C metabolism in sheep. Identification of trans-6,7-dihydroxydihydroaldrin and 9-(syn-epoxy) hydroxy-1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4,5,6,7,8,8 -octahydro-1,4-endo-5,8-exo-dimethanonaphthalene. J Agric Food Chem 18(1):120–124
40. Fornage M, Boerwinkle E, Doris PA, Jacobs D, Liu K, Wong ND (2004) Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation 109(3):335–339. doi:10.1161/01.CIR.0000109487.46725.02
41. Fretland AJ, Omiecinski CJ (2000) Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact 129(1–2):41–59. doi:10.1016/S0009-2797(00)00197-6
42. Friedberg T, Becker R, Oesch F, Glatt H (1994a) Studies on the importance of microsomal epoxide hydrolase in the detoxification of arene oxides using the heterologous expression of the enzyme in mammalian cells. Carcinogenesis 15(2):171–175
43. Friedberg T, Lollmann B, Becker R, Holler R, Oesch F (1994b) The microsomal epoxide hydrolase has a single membrane signal anchor sequence which is dispensable for the catalytic activity of this protein. Biochem J 303(Pt 3):967–972
44. Gaedigk A, Spielberg SP, Grant DM (1994) Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics 4(3):142–153
45. Gebhardt GS, Peters WH, Hillermann R et al (2004) Maternal and fetal single nucleotide polymorphisms in the epoxide hydrolase and glutathione S-transferase P1 genes are not associated with pre-eclampsia in the Coloured population of the Western Cape South Africa. J Obstet Gynaecol 24(8):866–872. doi:10.1080/01443610400018841
46. Ghattas MH, Amer MA (2012) Possible role of microsomal epoxide hydrolase gene polymorphism as a risk factor for developing insulin resistance and type 2 diabetes mellitus. Endocrine 42(3):577–583. doi:10.1007/s12020-012-9656-5
47. Ghoshal U, Kumar S, Jaiswal V, Tripathi S, Mittal B, Ghoshal UC (2013) Association of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India. Indian J Gastroenterol. doi:10.1007/s12664-013-0332-3
48. Gill SS, Hammock BD (1980) Distribution and properties of a mammalian soluble epoxide hydrase. Biochem Pharmacol 29(3):389–395. doi:10.1016/0006-2952(80)90518-3
49. Gill SS, Ota K, Ruebner B, Hammock BD (1983) Microsomal and cytosolic epoxide hydrolases in rhesus monkey liver, and in normal and neoplastic human liver. Life Sci 32(23):2693–2700
50. Glatt H, Wameling C, Elsberg S et al (1993) Genotoxicity characteristics of reverse diol-epoxides of chrysene. Carcinogenesis 14(1):11–19
51. Gomez GA, Morisseau C, Hammock BD, Christianson DW (2004) Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis. Biochemistry 43(16):4716–4723. doi:10.1021/bi036189j
52. Grant DF, Storms DH, Hammock BD (1993) Molecular cloning and expression of murine liver soluble epoxide hydrolase. J Biol Chem 268(23):17628–17633
53. Guengerich FP, Johnson WW, Ueng YF, Yamazaki H, Shimada T (1996) Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ Health Perspect 104(Suppl 3):557–562
54. Guengerich FP, Johnson WW, Shimada T, Ueng YF, Yamazaki H, Langouet S (1998) Activation and detoxication of aflatoxin B1. Mutat Res 402(1–2):121–128. doi:10.1016/S0027-5107(97)00289-3
55. Hall M, Parker DK, Hewer AJ, Phillips DH, Grover PL (1988) Further metabolism of diol-epoxides of chrysene and dibenz[a, c]anthracene to DNA binding species as evidenced by 32P-postlabelling analysis. Carcinogenesis 9(5):865–868
56. Hammock BD, Grant DF, Storms DH (1997) Epoxide hydrolases, vol 3. Elsevier Science Ltd, Oxford
57. Hartsfield JK Jr, Holmes LB, Morel JG (1995) Phenytoin embryopathy: effect of epoxide hydrolase inhibitor on phenytoin exposure in utero in C57BL/6 J mice. Biochem Mol Med 56(2):131–143. doi:10.1006/bmme.1995.1068
58. Hartsfield JK Jr, Sutcliffe MJ, Everett ET, Hassett C, Omiecinski CJ, Saari JA (1998) Assignment1 of microsomal epoxide hydrolase (EPHX1) to human chromosome 1q42.1 by in situ hybridization. Cytogenet Cell Genet 83(1-2):44–45
59. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ (1994a) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3(3):421–428
60. Hassett C, Robinson KB, Beck NB, Omiecinski CJ (1994b) The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics 23(2):433–442. doi:10.1006/geno.1994.1520
61. Hattori N, Fujiwara H, Maeda M, Fujii S, Ueda M (2000) Epoxide hydrolase affects estrogen production in the human ovary. Endocrinology 141(9):3353–3365
62. Heflich RH, Thornton-Manning JR, Kinouchi T, Beland FA (1990) Mutagenicity of oxidized microsomal metabolites of 1-nitropyrene in Chinese hamster ovary cells. Mutagenesis 5(2):151–157
63. Herrero ME, Arand M, Hengstler JG, Oesch F (1997) Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide- but not from ethylene oxide-induced DNA strand breaks. Environ Mol Mutagen 30(4):429–439. doi:10.1002/(SICI)1098-2280(1997)30:4<429:AID-EM8>3.0.CO;2-D
64. Holder G, Yagi H, Dansette P et al (1974) Effects of inducers and epoxide hydrase on the metabolism of benzo(a)pyrene by liver microsomes and a reconstituted system: analysis by high pressure liquid chromatography. Proc Natl Acad Sci USA 71(11):4356–4360
65. Holler R, Arand M, Mecky A, Oesch F, Friedberg T (1997) The membrane anchor of microsomal epoxide hydrolase from human, rat, and rabbit displays an unexpected membrane topology. Biochem Biophys Res Commun 236(3):754–759. doi:10.1006/bbrc.1997.7044
66. Huang YF, Chiang SY, Liou SH et al (2012) The modifying effect of CYP2E1, GST, and mEH genotypes on the formation of hemoglobin adducts of acrylamide and glycidamide in workers exposed to acrylamide. Toxicol Lett 215(2):92–99. doi:10.1016/j.toxlet.2012.10.003
67. Ihsan R, Chattopadhyay I, Phukan R et al (2010) Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India. J Gastroenterol Hepatol 25(8):1456–1462. doi:10.1111/j.1440-1746.2010.06354.x
68. Imig JD (2012) Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev 92(1):101–130. doi:10.1152/physrev.00021.2011
69. Inceoglu B, Jinks SL, Schmelzer KR, Waite T, Kim IH, Hammock BD (2006) Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. Life Sci 79(24):2311–2319. doi:10.1016/j.lfs.2006.07.031
70. Inceoglu B, Jinks SL, Ulu A et al (2008) Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. Proc Natl Acad Sci USA 105(48):18901–18906. doi:10.1073/pnas.0809765105
71. Ioannides C (2002) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, Chichester
72. Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B (2008) Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol 230(2):247–251. doi:10.1016/j.taap.2008.02.023
73. Kamal MA, Elsaadany ZA, Fouad NB et al (2012) Genetic polymorphism of microsomal epoxide hydrolase enzyme gene in preeclamptic females. Am J Med Sci 343(4):291–294. doi:10.1097/MAJ.0b013e31822be635
74. Kerr BM, Levy RH (1989) Inhibition of epoxide hydrolase by anticonvulsants and risk of teratogenicity. Lancet 1(8638):8610–8611
75. Kerr BM, Rettie AE, Eddy AC et al (1989) Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation. Clin Pharmacol Ther 46(1):82–93
76. Khedhaier A, Hassen E, Bouaouina N, Gabbouj S, Ahmed SB, Chouchane L (2008) Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer 8:109. doi:10.1186/1471-2407-8-109
77. Kodama M, Ioki Y, Nagata C (1980) Dose-dependent effect of trichloropropene oxide on benzo[a]pyrene carcinogenesis. J Cancer Res Clin Oncol 98(1):105–107
78. Koerner IP, Jacks R, DeBarber AE et al (2007) Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury. J Neurosci 27(17):4642–4649. doi:10.1523/JNEUROSCI.0056-07.2007
79. Korhonen S, Romppanen EL, Hiltunen M et al (2003) Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome. Fertil Steril 79(6):1353–1357. doi:10.1016/S0015-0282(03)00385-6
80. Laasanen J, Romppanen EL, Hiltunen M et al (2002) Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia. Eur J Hum Genet 10(9):569–573. doi:10.1038/sj.ejhg.5200849
81. Lacourciere GM, Vakharia VN, Tan CP et al (1993) Interaction of hepatic microsomal epoxide hydrolase derived from a recombinant baculovirus expression system with an azarene oxide and an aziridine substrate analogue. Biochemistry 32(10):2610–2616
82. Lakhdar R, Denden S, Mouhamed MH et al (2011) Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease. Exp Lung Res 37(4):195–204. doi:10.3109/01902148.2010.535093
83. Lancaster JM, Brownlee HA, Bell DA et al (1996) Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17(3):160–162. doi:10.1002/(SICI)1098-2744(199611)17:3<160:AID-MC8>3.0.CO;2-J
84. Lee CR, North KE, Bray MS et al (2006) Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Hum Mol Genet 15(10):1640–1649. doi:10.1093/hmg/ddl085
85. Lee CR, Pretorius M, Schuck RN et al (2011) Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans. Hypertension 57(1):116–122. doi:10.1161/HYPERTENSIONAHA.110.161695
86. Li H, Fu WP, Hong ZH (2013) Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: a comprehensive meta-analysis. Oncol Lett 5(3):1022–1030. doi:10.3892/ol.2012.1099
87. Lin YC, Wu DC, Lee JM et al (2006) The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: interaction between areca chewing and smoking. Cancer Lett 237(2):281–288. doi:10.1016/j.canlet.2005.06.010
88. Liu M, Sun A, Shin EJ et al (2006) Expression of microsomal epoxide hydrolase is elevated in Alzheimer’s hippocampus and induced by exogenous beta-amyloid and trimethyl-tin. Eur J Neurosci 23(8):2027–2034. doi:10.1111/j.1460-9568.2006.04724.x
89. Liu M, Hunter R, Nguyen XV, Kim HC, Bing G (2008) Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. J Neurosci Res 86(12):2792–2801. doi:10.1002/jnr.21725
90. Liu F, Yuan D, Wei Y et al (2012) Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk. PLoS One 7(8):e43821. doi:10.1371/journal.pone.0043821
91. Liu H, Li HY, Chen HJ, Huang YJ, Zhang S, Wang J (2013) EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis. Tumour Biol 34(1):155–163. doi:10.1007/s13277-012-0523-z
92. Malvoisin E, Roberfroid M (1982) Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica; the fate of foreign compounds in biological systems 12(2):137–144
93. McHale CM, Zhang L, Smith MT (2012) Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis 33(2):240–252. doi:10.1093/carcin/bgr297
94. Meijer J, DePierre JW (1988) Cytosolic epoxide hydrolase. Chem Biol Interact 64(3):207–249
95. Meijer JW, Binnie CD, Debets RM, van Parys JA, de Beer-Pawlikowski NK (1984) Possible hazard of valpromide-carbamazepine combination therapy in epilepsy. Lancet 1(8380):8802
96. Mendrala AL, Langvardt PW, Nitschke KD, Quast JF, Nolan RJ (1993) In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human. Arch Toxicol 67(1):18–27
97. Mitchell LA, Moran JH, Grant DF (2002) Linoleic acid, cis-epoxyoctadecenoic acids, and dihydroxyoctadecadienoic acids are toxic to Sf-21 cells in the absence of albumin. Toxicol Lett 126(3):187–196. doi:10.1016/S0378-4274(01)00463-5
98. Mittal RD, Srivastava DL (2007) Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. DNA Cell Biol 26(11):791–798. doi:10.1089/dna.2007.0630
99. Miyata M, Kudo G, Lee YH et al (1999) Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J Biol Chem 274(34):23963–23968
100. Moran JH, Weise R, Schnellmann RG, Freeman JP, Grant DF (1997) Cytotoxicity of linoleic acid diols to renal proximal tubular cells. Toxicol Appl Pharmacol 146(1):53–59. doi:10.1006/taap.1997.8197
101. Morisseau C (2013) Role of epoxide hydrolases in lipid metabolism. Biochimie 95(1):91–95. doi:10.1016/j.biochi.2012.06.011
102. Morisseau C, Hammock BD (2005) Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 45:311–333. doi:10.1146/annurev.pharmtox.45.120403.095920
103. Morisseau C, Hammock BD (2013) Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 53:37–58. doi:10.1146/annurev-pharmtox-011112-140244
104. Morisseau C, Du G, Newman JW, Hammock BD (1998) Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives. Arch Biochem Biophys 356(2):214–228. doi:10.1006/abbi.1998.0756
105. Morisseau C, Goodrow MH, Dowdy D et al (1999) Potent urea and carbamate inhibitors of soluble epoxide hydrolases. Proc Natl Acad Sci USA 96(16):8849–8854
106. Morisseau C, Newman JW, Dowdy DL, Goodrow MH, Hammock BD (2001) Inhibition of microsomal epoxide hydrolases by ureas, amides, and amines. Chem Res Toxicol 14(4):409–415. doi:10.1021/tx0001732
107. Morisseau C, Newman JW, Wheelock CE et al (2008) Development of metabolically stable inhibitors of mammalian microsomal epoxide hydrolase. Chem Res Toxicol 21(4):951–957. doi:10.1021/tx700446u
108. Munter T, Cottrell L, Golding BT, Watson WP (2003) Detoxication pathways involving glutathione and epoxide hydrolase in the in vitro metabolism of chloroprene. Chem Res Toxicol 16(10):1287–1297. doi:10.1021/tx034107m
109. Nebert DW, Dalton TP (2006) The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 6(12):947–960. doi:10.1038/nrc2015
110. Nelson JW, Subrahmanyan RM, Summers SA, Xiao X, Alkayed NJ (2013) Soluble epoxide hydrolase dimerization is required for hydrolase activity. J Biol Chem 288(11):7697–7703. doi:10.1074/jbc.M112.429258M112.429258
111. Newman JW, Morisseau C, Harris TR, Hammock BD (2003) The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc Natl Acad Sci USA 100(4):1558–1563. doi:10.1073/pnas.04377241000437724100
112. Newman JW, Morisseau C, Hammock BD (2005) Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res 44(1):1–51. doi:10.1016/j.plipres.2004.10.001
113. Nock NL, Liu X, Cicek MS et al (2006) Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 15(4):756–761. doi:10.1158/1055-9965.EPI-05-0826
114. Nock NL, Tang D, Rundle A et al (2007) Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol Biomarkers Prev 16(6):1236–1245. doi:10.1158/1055-9965.EPI-06-0736
115. Norwood S, Liao J, Hammock BD, Yang GY (2010) Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis. Am J Transl Res 2(4):447–457
116. Oesch F, Raphael D, Schwind H, Glatt HR (1977) Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites. Arch Toxicol 39(1–2):97–108
117. Oesch F, Herrero ME, Hengstler JG, Lohmann M, Arand M (2000) Metabolic detoxification: implications for thresholds. Toxicol Pathol 28(3):382–387
118. Oesch F, Hengstler JG, Arand M (2004) Detoxication strategy of epoxide hydrolase-the basis for a novel threshold for definable genotoxic carcinogens. Nonlinearity Biol Toxicol Med 2(1):21–26. doi:10.1080/15401420490426963
119. Ozawa T, Nishikimi M, Sugiyama S, Taki F, Hayakawa M, Shionoya H (1988) Cytotoxic activity of leukotoxin, a neutrophil-derived fatty acid epoxide, on cultured human cells. Biochem Int 16(2):369–373
120. Pace-Asciak CR, Lee WS (1989) Purification of hepoxilin epoxide hydrolase from rat liver. J Biol Chem 264(16):9310–9313
121. Pacifici GM, Rane A (1983) Epoxide hydrolase in human fetal liver. Pharmacology 26(5):241–248
122. Pang W, Li N, Ai D, Niu XL, Guan YF, Zhu Y (2011) Activation of peroxisome proliferator-activated receptor-gamma downregulates soluble epoxide hydrolase in cardiomyocytes. Clin Exp Pharmacol Physiol 38(6):358–364. doi:10.1111/j.1440-1681.2011.05492.x
123. Papadopoulos D, Jornvall H, Rydstrom J, DePierre JW (1994) Purification and initial characterization of microsomal epoxide hydrolase from the human adrenal gland. Biochim Biophys Acta 1206(2):253–262
124. Pinarbasi E, Percin FE, Yilmaz M, Akgun E, Cetin M, Cetin A (2007) Association of microsomal epoxide hydrolase gene polymorphism and pre-eclampsia in Turkish women. J Obstet Gynaecol Res 33(1):32–37. doi:10.1111/j.1447-0756.2007.00473.x
125. Pinot F, Grant DF, Spearow JL, Parker AG, Hammock BD (1995) Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice. Biochem Pharmacol 50(4):501–508. doi:10.1016/0006-2952(95)00167-X
126. Pisani F, Haj-Yehia A, Fazio A et al (1993) Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation. Epilepsia 34(5):954–959
127. Podolin PL, Bolognese BJ, Foley JF et al (2013) In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor. Prostaglandins Other Lipid Mediat 104–105:25–31. doi:10.1016/j.prostaglandins.2013.02.001
128. Porter TD, Beck TW, Kasper CB (1986) Complementary DNA and amino acid sequence of rat liver microsomal, xenobiotic epoxide hydrolase. Arch Biochem Biophys 248(1):121–129. doi:10.1016/0003-9861(86)90408-X
129. Przybyla-Zawislak BD, Srivastava PK, Vazquez-Matias J et al (2003) Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 64(2):482–490. doi:10.1124/mol.64.2.482
130. Raijmakers MT, de Galan-Roosen TE, Schilders GW, Merkus JM, Steegers EA, Peters WH (2004) The Tyr113His polymorphism in exon 3 of the microsomal epoxide hydrolase gene is a risk factor for perinatal mortality. Acta Obstet Gynecol Scand 83(11):1056–1060. doi:10.1111/j.0001-6349.2004.00455.x
131. Rambeck B, Salke-Treumann A, May T, Boenigk HE (1990) Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents. Eur Neurol 30(2):79–83
132. Ramirez D, Lammer EJ, Iovannisci DM, Laurent C, Finnell RH, Shaw GM (2007) Maternal smoking during early pregnancy, GSTP1 and EPHX1 variants, and risk of isolated orofacial clefts. Cleft Palate Craniofac J 44(4):366–373. doi:10.1597/06-011.1
133. Rao NL, Riley JP, Banie H et al (2010) Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 181(9):899–907. doi:10.1164/rccm.200807-1158OC
134. Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82(1):131–185. doi:10.1152/physrev.00021.2001
135. Rossi AM, Migliore L, Lascialfari D et al (1983a) Genotoxicity, metabolism and blood kinetics of epichlorohydrin in mice. Mutat Res 118(3):213–226. doi:10.1016/0165-1218(83)90144-1
136. Rossi AM, Migliore L, Loprieno N, Romano M, Salmona M (1983b) Evaluation of epichlorohydrin (ECH) genotoxicity. Microsomal epoxide hydrolase-dependent deactivation of ECH mutagenicity in Schizosaccharomyces pombe in vitro. Mutat Res 109(1):41–52. doi:10.1016/0027-5107(83)90093-3
137. Samokhvalov V, Alsaleh N, El-Sikhry HE et al (2013) Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response. Cell Death Dis 4:e885. doi:10.1038/cddis.2013.418
138. Sandberg M, Hassett C, Adman ET, Meijer J, Omiecinski CJ (2000) Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem 275(37):28873–28881. doi:10.1074/jbc.M001153200
139. Sarmanova J, Susova S, Gut I et al (2004) Breast cancer: role of polymorphisms in biotransformation enzymes. Eur J Hum Genet 12(10):848–854. doi:10.1038/sj.ejhg.5201249
140. Schladt L, Hartmann R, Timms C et al (1987) Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds. Biochem Pharmacol 36(3):345–351
141. Schmelzer KR, Inceoglu B, Kubala L et al (2006) Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA 103(37):13646–13651. doi:10.1073/pnas.0605908103
142. Shen HC, Hammock BD (2012) Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. J Med Chem 55(5):1789–1808. doi:10.1021/jm201468j
143. Shou M, Gonzalez FJ, Gelboin HV (1996) Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. Biochemistry 35(49):15807–15813. doi:10.1021/bi962042z
144. Sims P, Grover PL, Swaisland A, Pal K, Hewer A (1974) Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature 252(5481):326–328
145. Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, Gonzalez FJ (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275(51):40504–40510. doi:10.1074/jbc.M008106200
146. Sivonova MK, Dobrota D, Matakova T et al (2012) Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population. Neoplasma 59(1):79–84
147. Slim R, Hammock BD, Toborek M et al (2001) The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells. Toxicol Appl Pharmacol 171(3):184–193. doi:10.1006/taap.2001.9131
148. Smith KR, Pinkerton KE, Watanabe T, Pedersen TL, Ma SJ, Hammock BD (2005) Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci USA 102(6):2186–2191. doi:10.1073/pnas.0409591102
149. Snider NT, Kornilov AM, Kent UM, Hollenberg PF (2007) Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. J Pharmacol Exp Ther 321(2):590–597. doi:10.1124/jpet.107.119321
150. Snyder R, Chepiga T, Yang CS, Thomas H, Platt K, Oesch F (1993) Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicol Appl Pharmacol 122(2):172–181. doi:10.1006/taap.1993.1185
151. Sonzogni L, Silvestri L, De Silvestri A et al (2002) Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. Hepatology 36(1):195–201. doi:10.1053/jhep.2002.33898
152. Spurdle AB, Purdie DM, Webb PM, Chen X, Green A, Chenevix-Trench G (2001) The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer. Mol Carcinog 30(1):71–78. doi:10.1002/1098-2744(200101)30:1<71:AID-MC1015>3.0.CO;2-9
153. Spurdle AB, Chang JH, Byrnes GB et al (2007) A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(4):769–774. doi:10.1158/1055-9965.EPI-06-0776
154. Strickler SM, Dansky LV, Miller MA, Seni MH, Andermann E, Spielberg SP (1985) Genetic predisposition to phenytoin-induced birth defects. Lancet 2(8458):746–749
155. Sumner SJ, Fennell TR (1994) Review of the metabolic fate of styrene. Crit Rev Toxicol 24(Suppl):S11–S33. doi:10.3109/10408449409020138
156. Taura Ki K, Yamada H, Naito E, Ariyoshi N, Mori Ma MA, Oguri K (2002) Activation of microsomal epoxide hydrolase by interaction with cytochromes P450: kinetic analysis of the association and substrate-specific activation of epoxide hydrolase function. Arch Biochem Biophys 402(2):275–280. doi:10.1016/S0003-9861(02)00079-6S0003-9861(02)00079-6
157. Terashvili M, Tseng LF, Wu HE et al (2008) Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray. J Pharmacol Exp Ther 326(2):614–622. doi:10.1124/jpet.108.136739
158. Thomas EW, McKelvy JF, Sharon N (1969) Specific and irreversible inhibition of lysozyme by 2′,3′-epoxypropyl beta-glycosides of N-acetyl-D-glucosamine oligomers. Nature 222(5192):485–486
159. Thomas H, Schladt L, Knehr M, Oesch F (1989) Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione S-transferases and peroxisomal beta-oxidation. Biochem Pharmacol 38(23):4291–4297
160. Thomas H, Schladt L, Doehmer J, Knehr M, Oesch F (1990) Rat and human liver cytosolic epoxide hydrolases: evidence for multiple forms at level of protein and mRNA. Environ Health Perspect 88:49–55
161. Thunnissen MM, Nordlund P, Haeggstrom JZ (2001) Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation. Nat Struct Biol 8(2):131–135. doi:10.1038/84117
162. Toivonen S, Romppanen EL, Hiltunen M et al (2004) Low-activity haplotype of the microsomal epoxide hydrolase gene is protective against placental abruption. J Soc Gynecol Investig 11(8):540–544. doi:10.1016/j.jsgi.2004.06.008
163. Tumer TB, Sahin G, Arinc E (2012) Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia. Arch Toxicol 86(3):431–439. doi:10.1007/s00204-011-0760-8
164. Vibhuti A, Arif E, Deepak D, Singh B, Qadar Pasha MA (2007) Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Biochem Biophys Res Commun 359(1):136–142. doi:10.1016/j.bbrc.2007.05.076
165. Vogel-Bindel U, Bentley P, Oesch F (1982) Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate. Eur J Biochem/FEBS 126(2):425–431
166. von Dippe P, Zhu QS, Levy D (2003) Cell surface expression and bile acid transport function of one topological form of m-epoxide hydrolase. Biochem Biophys Res Commun 309(4):804–809. doi:10.1016/j.bbrc.2003.08.074
167. Wang LD, Zheng S, Liu B, Zhou JX, Li YJ, Li JX (2003) CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China. World J Gastroenterol 9(7):1394–1397
168. Wang Z, Tang L, Sun G et al (2006) Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian. China. BMC Cancer 6:287. doi:10.1186/1471-2407-6-287
169. Wang L, Yang J, Guo L et al (2012) Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 46(5):614–622. doi:10.1165/rcmb.2011-0359OC2011-0359OC
170. Ward EM, Fajen JM, Ruder AM, Rinsky RA, Halperin WE, Fessler-Flesch CA (1996) Mortality study of workers employed in 1,3-butadiene production units identified from a large chemical workers cohort. Toxicology 113(1–3):157–168
171. Watabe T, Komatsu T, Isobe M, Tsubaki A (1983) Mouse liver microsomal cholesterol epoxide hydrolase: a specific inhibition of its activity by 5,6 alpha-Imino-5 alpha-cholestan-3 alpha-OL. Chem Biol Interact 44(1–2):143–154
172. Wickliffe JK, Ammenheuser MM, Salazar JJ et al (2003) A model of sensitivity: 1,3-butadiene increases mutant frequencies and genomic damage in mice lacking a functional microsomal epoxide hydrolase gene. Environ Mol Mutagen 42(2):106–110. doi:10.1002/em.10181
173. Wildhaber BE, Yang H, Tazuke Y, Teitelbaum DH (2003) Gene alteration of intestinal intraepithelial lymphocytes with administration of total parenteral nutrition. J Pediatr Surg 38(6):840–843. doi:10.1016/S0022-3468(03)00107-6
174. Wray J, Bishop-Bailey D (2008) Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology. Exp Physiol 93(1):148–154. doi:10.1113/expphysiol.2007.038612
175. Sudhahar V, Shaw S, Imig JD (2010) Epoxyeicosatrienoic acid analogs and vascular function. Curr Med Chem 17(12):1181–1190
176. Zakim D, Vessey DA (1985) Biochemical pharmacology and toxicology. Wiley, New York
177. Zeldin DC, Kobayashi J, Falck JR et al (1993) Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem 268(9):6402–6407
178. Zeldin DC, Moomaw CR, Jesse N et al (1996) Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 330(1):87–96. doi:10.1006/abbi.1996.0229
179. Zhang JH, Jin X, Li Y et al (2003) Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China. World J Gastroenterol 9(12):2654–2657
180. Zhang D, Xie X, Chen Y, Hammock BD, Kong W, Zhu Y (2012) Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Circ Res 110(6):808–817. doi:10.1161/CIRCRESAHA.111.259325
181. Zheng J, Cho M, Jones AD, Hammock BD (1997) Evidence of quinone metabolites of naphthalene covalently bound to sulfur nucleophiles of proteins of murine Clara cells after exposure to naphthalene. Chem Res Toxicol 10(9):1008–1014. doi:10.1021/tx970061j
182. Zhong JH, Xiang BD, Ma L, You XM, Li LQ, Xie GS (2013) Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma. PLoS ONE 8(2):e57064. doi:10.1371/journal.pone.0057064
183. Zhu Q, von Dippe P, Xing W, Levy D (1999) Membrane topology and cell surface targeting of microsomal epoxide hydrolase. Evidence for multiple topological orientations. J Biol Chem 274(39):27898–27904
184. Zou J, Hallberg BM, Bergfors T et al (2000) Structure of Aspergillus niger epoxide hydrolase at 1.8 A resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases. Structure 8(2):111–122. doi:10.1016/S0969-2126(00)00087-3
185. Zusterzeel PL, Peters WH, Visser W, Hermsen KJ, Roelofs HM, Steegers EA (2001) A polymorphism in the gene for microsomal epoxide hydrolase is associated with preeclampsia. J Med Genet 38(4):234–237